Search results

A connection between SARS-CoV-2 antibodies and immunity remains uncertain
www.richmondresearchinstitute.org/news/a-connection-between-sars-cov-2-antibodies-and-immunity-remains-uncertain

A connection between SARS-CoV-2 antibodies and immunity remains uncertain. Covid-19. Vaccines. Antibodies. 23rd February 2021. Uncertainty remains in the connection between SARS antibodies and immunity. Our recent research findings – which concur with a.

Interactive SVG
www.richmondresearchinstitute.org/dev/interactive-svg

By repeating these tests over time, we can establish how long the antibodies take to develop and how long immunity lasts in each person. The graphs above show that the number of weekly tests has decreased in recent weeks.

COVID-19 Testing - Richmond Research Institute
www.richmondresearchinstitute.org/dev/covid-19-testing

We have also continued to test for antibodies. By repeating these tests over time, we can establish how long the antibodies take to develop and how long immunity may last in each person.

COVID-19 Testing - Richmond Research Institute
www.richmondresearchinstitute.org/dev/backup-covid-19-testing

We have also continued to test for antibodies. By repeating these tests over time, we can establish how long the antibodies take to develop and how long immunity may last in each person.

COVID-19 Testing - Richmond Research Institute
www.richmondresearchinstitute.org/covid-19/testing

We have also continued to test for antibodies to both infection and vaccine. By repeating these tests over time, we can establish how long the antibodies take to develop and how long immunity may last in each person.

COVID-19 Testing Archive oct 2020
www.richmondresearchinstitute.org/dev/covid-19-testing-archive-oct-2020

We have also continued to test for antibodies. By repeating these tests over time, we can establish how long the antibodies take to develop and how long immunity may last in each person.

COVID-19 Testing - Richmond Research Institute
www.richmondresearchinstitute.org/dev/covid-19-testing-copy

We have also continued to test for antibodies. By repeating these tests over time, we can establish how long the antibodies take to develop and how long immunity may last in each person.

News - Richmond Research Institute
www.richmondresearchinstitute.org/news

Antibodies. Vaccines. Why more caution is needed in administering QT prolonging drugs to type 1 diabetic patients.

Making our local community safer by COVID-19 testing
www.richmondresearchinstitute.org/news/making-our-local-community-safer-by-covid-19-testing-2

Antibodies. Vaccines. Our results suggest that individuals who have previously been infected with SARS-CoV-2 achieve markedly higher antibody titres than those who have yet to show signs of infection.

Richmond Research Institute asks the question, 'Can a second booster dose be delayed in patients who have COVID-19?'
www.richmondresearchinstitute.org/news/richmond-research-institute-asks-the-question-do-post-covid-19-patients-need-a-second-dose-of-vaccine

Antibodies. Vaccines. 20th April 2021. Published COVID-19 Research. Richmond Research Institute is actively involved in COVID-19 symptoms testing for all staff and visitors who attempt entry to Richmond Pharmacology's London Bridge clinical trial unit.

We work with partners at the following organisations: 

richmond research institute

We have a track record in conducting clinical research.

Publications

We present our scientific findings at meetings.

Videos

Our academic research helps improve lives and strengthens scientific insights.

Research